Consumer9/15/2026

Ministry of Health Warned of Sibutramine in G-Slim Weight-Loss Capsules

The Israeli Ministry of Health announced that G-Slim weight-loss capsules had not received its approval. Testing of the product detected a high concentration of sibutramine.

Key facts

•Product: G-Slim weight-loss capsules
•Substance: Sibutramine
•Concentration: Three times higher than the dosage in a comparable product that was previously banned
•Announcement date: September 15, 2026
•Authority: Israeli Ministry of Health

What the Test Found

The announcement was issued following inspection and oversight activities by the Ministry of Health. According to the ministry, the sibutramine content in one G-Slim capsule was three times higher than the dosage in a similar product that had previously been removed from the market for being illegal.

Why the Warning Was Issued

Shortly before the announcement, a young man suffering from chest pain and a rapid heartbeat was hospitalized. The source provides no further medical details and does not explicitly establish a causal link between taking G-Slim and the hospitalization.

The Product’s Status

The Ministry of Health stated that G-Slim is not approved by it and that it contains a prohibited medicinal substance. The source does not name the seller or manufacturer, specify the distribution channels, or report any legal proceedings or penalty imposed.

What this means for you

Purchasers of weight-loss products should bear in mind that selling a product as a dietary supplement or in capsule form does not indicate that it has been approved by the Ministry of Health. The announcement points to the risk that G-Slim contains an undeclared medicinal substance; the source does not include detailed instructions for returning the product or information on how those harmed should seek assistance.

Find a lawyer for this topic

Case analysis based on court rulings